Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1831013
Max Phase: Preclinical
Molecular Formula: C24H28Cl2N4
Molecular Weight: 406.96
Molecule Type: Small molecule
Associated Items:
ID: ALA1831013
Max Phase: Preclinical
Molecular Formula: C24H28Cl2N4
Molecular Weight: 406.96
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)CCCNCc1nccc2c3ccccc3n(Cc3cccc(Cl)c3)c12.Cl
Standard InChI: InChI=1S/C24H27ClN4.ClH/c1-28(2)14-6-12-26-16-22-24-21(11-13-27-22)20-9-3-4-10-23(20)29(24)17-18-7-5-8-19(25)15-18;/h3-5,7-11,13,15,26H,6,12,14,16-17H2,1-2H3;1H
Standard InChI Key: NJQKTSNAFODOMP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 406.96 | Molecular Weight (Monoisotopic): 406.1924 | AlogP: 4.93 | #Rotatable Bonds: 8 |
Polar Surface Area: 33.09 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.48 | CX LogP: 4.14 | CX LogD: 1.99 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.42 | Np Likeness Score: -1.18 |
1. Chen Z, Cao R, Shi B, Guo L, Sun J, Ma Q, Fan W, Song H.. (2011) Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents., 46 (10): [PMID:21875764] [10.1016/j.ejmech.2011.08.027] |
Source(1):